Kappos’ Early Days At USPTO: Many Changes, Few Funds 23/10/2009 by Dugie Standeford for Intellectual Property Watch 1 Comment Reform of the United States patent system, better patent quality and greater international cooperation among patent offices are just a few of the jobs new United States Patent and Trademark Office chief David Kappos has on his plate.
Spurring Local Innovation In Africa By Improving Access To Information 19/10/2009 by Robinson Esalimba for Intellectual Property Watch and William New 1 Comment Greater awareness of the existence of open access information resources for innovation and making the information easily accessible and relevant to developing country users could help spur innovation in these countries, according to top technical assistance providers and local innovators.
How The “Machine-Or-Transformation” Test In Bilski Is Failing 16/10/2009 by Intellectual Property Watch 5 Comments Charles Macedo and Norajean McCaffrey write that in the upcoming Supreme Court case on the Bilksi “machine-or-transformation” test, the Federal Circuit departed from Supreme Court precedent, and they suggest how to put the law of patent-eligible subject matter back on track.
European Union Prepares A New Intellectual Property Rights Strategy 15/10/2009 by Monika Ermert for Intellectual Property Watch 5 Comments Intellectual property rights and their protection will be high on the agenda of the European institutions in the upcoming legislature, representatives from the European Commission, European Council and the European Parliament said at the first European Innovation Summit in Brussels yesterday. Stronger IP rights (IPR) protection was declared by representatives of all three institutions as indispensable to promote innovation and the knowledge society, while only a few voices were raised asking not to overreach in IPR regulation.
Pour les experts, l’accès à des médicaments sûrs est une question de santé publique et non de propriété intellectuelle 15/10/2009 by Catherine Saez, Intellectual Property Watch 1 Comment Selon les participants à un récent événement organisé par Open Society Institute, les initiatives de lutte contre la contrefaçon pourraient limiter l’accès aux traitements sans pour autant réduire le problème des médicaments contrefaits, en particulier dans les pays en développement.
专家组：获取安全药品是公共卫生问题而非知识产权问题 15/10/2009 by Catherine Saez, Intellectual Property Watch Leave a Comment 在最近由开放社会协会（Open Society Institute）主办的一次会议上，与会专家表示，反假冒倡议可能阻碍人们获得药品，但无法解决假药问题，在发展中国家尤其如此。
Grupo de expertos considera que el acceso a los medicamentos seguros es una cuestión de salud pública y no de propiedad intelectual 14/10/2009 by Catherine Saez, Intellectual Property Watch Leave a Comment Las iniciativas de lucha contra la falsificación podrían dificultar el acceso a los medicamentos sin que se logre paliar el problema de los fármacos falsificados, en particular en los países en desarrollo, según dijeron miembros de un grupo de expertos en un evento organizado recientemente por el Open Society Institute.
WTO Forum: Bypassing International Agreements May Hamper Medicines Access 11/10/2009 by Catherine Saez, Intellectual Property Watch 1 Comment Access to medicines in developing countries may be put at risk by European customs regulations and more broadly by trade provisions in most free trade agreements between developed and developing countries, said speakers at the recent World Trade Organization Public Forum.
Council Of Europe Weighs Future; Drafts Counterfeit Medicines Convention 09/10/2009 by Monika Ermert for Intellectual Property Watch Leave a Comment Sixty years after its foundation, the Council of Europe is reconsidering its role and place in the architecture of European institutions. One new development is the drafting of a convention against medicines counterfeiting.
Iceland Panel: French ‘3-Strike’ Rule Spreading But Not Best Option 07/10/2009 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment COPENHAGEN – A panel discussing the copyright challenges posed by social media at a recent conference in Iceland concluded that while new and stricter regulations as proposed in France may not be a bad idea, the best solution is to provide consumers with quality services for which they are willing to pay. Meanwhile, there are new developments at the European level.